Pharmafile Logo

Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Learn more about how we are Shortening the distance from lab to life® at syneoshealth.com.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups.

View Profile

Page & Page Health

Page & Page is an independent creative agency on a mission to close the healthcare gap through the power of imaginative communication.

View Profile

Red Thread Market Access Ltd

Blending brilliant writing with in-depth market access and reimbursement expertise

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

SEVEN STONES COLLECTIVE

Great creativity leads to good health. We combine robust, evidence-based science with insight-driven, impactful creative ideas to find ways for brands to improve health. That’s why we call ourselves the…

View Profile

Springer Health+

Since 1982, Springer Health+ has delivered trusted healthcare education and communications. Medical progress is more than just science, and with people at the core of everything we do, our expertise…

View Profile

Springer Nature

Did you know that we publish over 3,000 journals, and that over 1,000 of those are clinical science journals? Promote your approved branded drugs and medical devices to our audience…

View Profile

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Twelve Marketing

Twelve delivers healthcare communications that drive Change for Good. We support pharma and medtech clients with strategic marketing, behaviour-led campaigns, and purposeful PR, helping teams engage professionals and the public,…

View Profile

Uniphar

Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.

View Profile

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that we attend each year.

View Profile

Wizzard

We are Wizzard: an independently owned, fully-integrated medical communications agency that is committed to crafting brilliant and engaging work. We work alongside you to cultivate a deep understanding of your…

View Profile

Company Details

, 10 Bloomsbury Way, London, WC1A 2SL, UK
+44 (0) 207 632 1800

 Latest Content from PMHub 

Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?

Press Releases | December 23, 2025 | Medscape Education

Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.

Does Rare Disease Education Work?

Press Releases | December 23, 2025 | Medscape Education

For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.

From Genetic Puzzles to Precision Therapeutics

Press Releases | December 23, 2025 | Medscape Education

How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more...

Medscape and the GNNRD: Empowering Nurses With a Rare Disease Education Series

Press Releases | December 23, 2025 | Medscape Education

Nurses play a vital and multifaceted role in rare disease care, providing consistent patient support, education, and care coordination, and ongoing education is essential to empower them to meet the...

What Is the RDI-Lancet Commission for Rare Disease and What Will It Achieve?

Press Releases | December 23, 2025 | Medscape Education

Christy Rohani-Montez, Medscape’s Rare Disease Education Lead recently spoke with Dr Lucy McKay, CEO, and Megan Pullein, Strategic Operations Officer from the UK-based charity Medics for Rare Disease (MfRD). We...

Pharma’s digital dilemma: Finding the balance between speed, scale, and experience

What’s holding pharma back from true digital transformation? At NEXT Pharma 2025, Our CEO Rob Verheul and Roeland van der Heiden (AstraZeneca) argued it starts with design systems. This quick...

Redefining digital ROI: Engagement, experience, and the new metrics of success

Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional KPIs to measure real impact and ROI from digital and...

Clinical research in 2026: The trends shaping tomorrow

Discover the key trends shaping clinical research in 2026, from patient-centric approaches to empowering site staff and fostering stronger human connections.

Lack of education causes patients to stop vital treatments, survey finds

Over three quarters of healthcare professionals call for co-created patient materials to drive engagement and trust, ultimately helping more patients benefit from prescribed treatments. Nearly 80% of healthcare professionals identify...